Moomoo AI 已提取核心信息
Cardio Diagnostics Holdings, Inc. has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, as per a correspondence dated January 30, 2024. The company has sought for the Registration Statement, with File No. 333-276725, to be declared effective on February 1, 2024, at 11:00 a.m. Eastern Time or as soon thereafter as practicable. This request was made under Rule 461 of the Securities Act of 1933, as amended. Cardio Diagnostics Holdings has indicated that once the Registration Statement is declared effective, the SEC should orally confirm the event with the company's counsel, Shartsis Friese LLP, specifically Rupert Russell. Any questions or comments from the SEC regarding this acceleration request are to be directed to Mr. Russell.
Cardio Diagnostics Holdings, Inc. has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, as per a correspondence dated January 30, 2024. The company has sought for the Registration Statement, with File No. 333-276725, to be declared effective on February 1, 2024, at 11:00 a.m. Eastern Time or as soon thereafter as practicable. This request was made under Rule 461 of the Securities Act of 1933, as amended. Cardio Diagnostics Holdings has indicated that once the Registration Statement is declared effective, the SEC should orally confirm the event with the company's counsel, Shartsis Friese LLP, specifically Rupert Russell. Any questions or comments from the SEC regarding this acceleration request are to be directed to Mr. Russell.
根据2024年1月30日的信函，Cardio Diagnostics Holdings, Inc.已正式要求美国证券交易委员会（SEC）加快其S-3表格注册声明的生效日期。该公司已寻求于美国东部时间2024年2月1日上午11点或此后在切实可行的情况下尽快宣布注册声明（文件编号为333-276725）生效。该请求是根据经修订的1933年《证券法》第461条提出的。Cardio Diagnostics Holdings表示，一旦宣布注册声明生效，美国证券交易委员会应与该公司的法律顾问Shartsis Friese LLP，特别是鲁珀特·罗素口头确认这一事件。美国证券交易委员会对该加速请求的任何问题或评论均应直接联系罗素先生。
根据2024年1月30日的信函，Cardio Diagnostics Holdings, Inc.已正式要求美国证券交易委员会（SEC）加快其S-3表格注册声明的生效日期。该公司已寻求于美国东部时间2024年2月1日上午11点或此后在切实可行的情况下尽快宣布注册声明（文件编号为333-276725）生效。该请求是根据经修订的1933年《证券法》第461条提出的。Cardio Diagnostics Holdings表示，一旦宣布注册声明生效，美国证券交易委员会应与该公司的法律顾问Shartsis Friese LLP，特别是鲁珀特·罗素口头确认这一事件。美国证券交易委员会对该加速请求的任何问题或评论均应直接联系罗素先生。
有用
没用
该公告为独立文件：